Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67 GBX | 0.00% | -5.63% | -0.74% |
May. 22 | EARNINGS AND TRADING: Adnams toasts increase in sales but loss widens | AN |
May. 22 | Feedback plc Provides Revenue Guidance for the Year 2024 | CI |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- With an enterprise value anticipated at 4.63 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.74% | 11.37M | - | ||
-4.87% | 29.6B | C | ||
+31.35% | 8.65B | C- | ||
+34.03% | 4.42B | B- | ||
-28.91% | 2.69B | C- | ||
-9.91% | 1.6B | - | C+ | |
-21.02% | 1.36B | B | ||
-35.78% | 1.1B | - | ||
+3.28% | 924M | C | ||
-43.36% | 791M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- FDBK Stock
- Ratings Feedback plc